These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31760102)

  • 21. Alterations in multiple tyrosine hydroxylase mRNAs in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated parkinsonian monkeys.
    Ohye T; Ichinose H; Ogawa M; Yoshida M; Nagatsu T
    Neurodegeneration; 1995 Mar; 4(1):81-5. PubMed ID: 7600187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.
    Subramanian T; Lieu CA; Guttalu K; Berg D
    Ultrasound Med Biol; 2010 Apr; 36(4):604-9. PubMed ID: 20211515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.
    El Massri N; Lemgruber AP; Rowe IJ; Moro C; Torres N; Reinhart F; Chabrol C; Benabid AL; Mitrofanis J
    Exp Brain Res; 2017 Jun; 235(6):1861-1874. PubMed ID: 28299414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
    Boska MD; Lewis TB; Destache CJ; Benner EJ; Nelson JA; Uberti M; Mosley RL; Gendelman HE
    J Neurosci; 2005 Feb; 25(7):1691-700. PubMed ID: 15716405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease.
    You LH; Li F; Wang L; Zhao SE; Wang SM; Zhang LL; Zhang LH; Duan XL; Yu P; Chang YZ
    Neuroscience; 2015 Jan; 284():234-246. PubMed ID: 25301748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P
    Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
    Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
    Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys.
    Taylor JR; Elsworth JD; Roth RH; Collier TJ; Sladek JR; Redmond DE
    Prog Brain Res; 1990; 82():543-59. PubMed ID: 2290957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.